Investigation into the effects of FK352 (a novel adenosine-1 receptor antagonist) in cirrhotic patients with ascites: A pilot study

被引：0
|
作者：
Stanley, AJ [1 ]
Forrest, EH [1 ]
Dabos, KJ [1 ]
Hayes, PC [1 ]
机构：
[1] ROYAL INFIRM,DEPT MED,EDINBURGH EH3 9YW,MIDLOTHIAN,SCOTLAND
来源：
HEPATOLOGY | 1996年 / 24卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1284 / 1284
页数：1
相关论文
共 50 条
  • [21] Effects of the 5-HT2A receptor antagonist sarpogrelate in diabetic patients with complications -: A pilot study
    Hotta, N
    Nakamura, J
    Sumita, Y
    Yasuda, K
    Ito, M
    Takeuchi, T
    Hara, T
    Sakamoto, N
    CLINICAL DRUG INVESTIGATION, 1999, 18 (03) : 199 - 207
  • [22] Cardio-Renal Effects of the A1 Adenosine Receptor Antagonist SLV320 in Patients With Heart Failure
    Mitrovic, Veselin
    Seferovic, Petar
    Dodic, Slobodan
    Krotin, Mirjana
    Neskovic, Aleksander
    Dickstein, Kenneth
    de Voogd, Hanka
    Boecker, Christiane
    Ziegler, Dieter
    Godes, Michael
    Nakov, Roumen
    Essers, Hans
    Verboom, Cees
    Hocher, Berthold
    CIRCULATION-HEART FAILURE, 2009, 2 (06) : 523 - 531
  • [23] V2 receptor antagonist (RWJ-351647) in patients with cirrhotic ascites: A randomised, double-blind, placebo controlled, single ascending dose study
    Thuluvath, PJ
    Maheshwari, A
    Wong, F
    Yoo, HY
    Schrier, RW
    Parikh, CR
    Steare, SE
    Korula, J
    GASTROENTEROLOGY, 2005, 128 (04) : A736 - A737
  • [24] Effects of BG9719 (CVT-124), a novel selective A1-adenosine receptor antagonist, on electrolyte excretion in patients with congestive heart failure
    Brater, DG
    Skettino, SL
    Wolff, AA
    Alto, P
    Beckman, E
    Gorski, JC
    Gottlieb, S
    Liittschwager, EB
    Mozill, D
    Garzone, P
    Bennett, D
    Refior, W
    Belardinelli, L
    CIRCULATION, 1998, 98 (17) : 81 - 81
  • [25] The PROTECT Pilot Study: A Randomized, Placebo-Controlled, Dose-Finding Study of the Adenosine A1 Receptor Antagonist Rolofylline in Patients With Acute Heart Failure and Renal Impairment
    Cotter, Gad
    Dittrich, Howard C.
    Weatherley, Beth Davison
    Bloomfield, Daniel M.
    O'Connor, Christopher M.
    Metra, Marco
    Massie, Barry M.
    JOURNAL OF CARDIAC FAILURE, 2008, 14 (08) : 631 - 640
  • [26] A NOVEL NONXANTHINE ADENOSINE-A1-RECEPTOR ANTAGONIST ATTENUATES THE NEGATIVE DROMOTROPIC EFFECTS, BUT NOT CORONARY DILATION, CAUSED BY ADENOSINE AND HYPOXIA IN GUINEA-PIG HEARTS
    BELARDINELLI, L
    COLEMAN, H
    BOYKIN, M
    CIRCULATION, 1990, 82 (04) : 150 - 150
  • [27] EFFECTS OF KW-3902, A NOVEL ADENOSINE A(1)-RECEPTOR ANTAGONIST, ON CEPHALORIDINE-INDUCED ACUTE-RENAL-FAILURE IN RATS
    NAGASHIMA, K
    KUSAKA, H
    SATO, K
    KARASAWA, A
    JAPANESE JOURNAL OF PHARMACOLOGY, 1994, 64 (01): : 9 - 17
  • [28] DIURETIC EFFECTS OF KW-3902, A NOVEL ADENOSINE A(1)-RECEPTOR ANTAGONIST, IN VARIOUS MODELS OF ACUTE-RENAL-FAILURE IN RATS
    YAO, K
    KUSAKA, H
    SANO, J
    SATO, K
    KARASAWA, A
    JAPANESE JOURNAL OF PHARMACOLOGY, 1994, 64 (04): : 281 - 288
  • [29] A PILOT STUDY OF GOLEXANOLONE, A NOVEL GABA-A RECEPTOR MODULATING STEROID ANTAGONIST, IN PATIENTS WITH CIRRHOSIS AND COVERT HEPATIC ENCEPHALOPATHY (HE).
    Montagnese, Sara
    Vilstrup, Hendrik Von Arenstorff
    Lauridsen, Mette
    Zarantonello, Lisa
    Lakner, Geza
    Fitilev, Sergey
    Kozlova, Irina
    Bunkova, Elena
    Tomasiewicz, Krzysztof
    Berglund, Jan Erik
    Mauney, Joe
    Thunarf, Frederik
    Mokhtarani, Masoud
    Backstrom, Torbjorn
    Doverskog, Magnus
    Lins, Lars-Erik
    Mansson, Maria
    Samuelson, Per
    Nilsson, Dag
    Schalling, Martin
    Johansson, Maja
    Arlander, Eva
    Scharschmidt, Bruce F.
    HEPATOLOGY, 2020, 72 : 1057 - 1058
  • [30] DOSE-RANGING STUDY OF N-0861, A NEW SELECTIVE-A1 RECEPTOR ANTAGONIST, IN PATIENTS RECEIVING ADENOSINE
    NAGASHIMA, S
    MOORE, HJ
    TRACY, CM
    SOLOMON, AJ
    HEWETTMEULMAN, JL
    COWLEY, SM
    WOOSLEY, RL
    BARBEY, JT
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1994, : A478 - A478
12345